www.stirlingproducts.net
Stirling Products (ASX:STI) is a manufacturer and marketer of proprietary and/or patented pharmaceutical products and natural health products for its own interests as well as on a contractual basis for third parties. Strategically, Stirling Products is positioned to capitalise on the rapidly changing conditions within the global pharmaceutical and health markets.
The Stirling Products corporate headquarters are in Sydney, Australia and its North American pharmaceutical manufacturing operations are based on Cape Breton, Nova Scotia, Canada.
Stirling operates through three main business units each managed by proven industry specialist managers:
- Pharmaceutical & Healthcare
- Research & Development
- Animal Products
Sorry, no articles available.
-
05/07/11
Stirling Products granted temporary suspension pending board and funding announcements -
01/07/11
Stirling Products in pre-open pending board and funding announcements -
22/06/11
Stirling Products agrees to sell controlling interest in TeleMedCare for A$3m -
17/06/11
Stirling Products boosts pharmaceutical exposure by winning Innovative New Product for KidneyVital™ -
15/06/11
Stirling Products conditional agreement for High Density Aerosol use in Russia -
10/06/11
Stirling Products in pre-open pending significant announcements -
07/06/11
Stirling Products in talks to appoint CEO, seeks London AIM listing -
30/05/11
Stirling Products agrees to collaborate on fast track development of ImmunoXel TB treatment -
09/05/11
Stirling Products receives strong interest in TeleMedCare from India, $5m letter of intent -
09/05/11
Stirling Products expects to be granted TeleMedCare rights within six months -
06/05/11
Stirling Products appoints former Pfizer director as CEO -
18/04/11
Stirling Products production and cash flows to commence at Canadian pharmaceutical plant -
07/04/11
Stirling Products Canadian pharmaceutical plant to commence production in April -
14/09/10
Stirling Products placed in pre-open pending acquisition announcement -
24/08/10
Stirling Products' TeleMedCare devices trialled by Boots Pharmacy -
18/08/10
Stirling Product's TeleMedCare, inks agreement with UK Government's central procurement agency -
13/08/10
Stirling Products' TeleMedCare units in major UK pharmacy pilot trial -
11/08/10
Stirling Products closes acquisition of TeleMedCare -
10/08/10
Stirling Products draws funding commitments of $3.9 million -
03/08/10
Stirling Products acquires controlling stake in TeleMedCare for A$7m -
30/07/10
Stirling Products in trading halt pending acquisition announcement -
23/07/10
Stirling Products clarifies funding facility for stake in TeleMedCare -
22/07/10
Stirling Products to acquire 65% stake in TeleMedCare Holdings -
15/07/10
Stirling Products issued with patent for obesity drug compound -
14/07/10
Stirling Products provides update on Canadian pharmaceutical plant -
05/07/10
Stirling Products advises of HIV treatment benefits of ImmunoXel in USA Study -
15/06/10
Stirling Products has options for development of drug delivery device -
07/06/10
Stirling Products rolls-out health line at Pharmacy Expo 2010 -
25/05/10
Stirling Products enters into major partnership with Kidney Health Australia -
13/05/10
Stirling Products appoints former ResMed director for drug inhalation device unit -
11/05/10
Stirling Products in product collaboration with Island Abbey Foods -
07/05/10
Stirling Products requests trading halt -
05/05/10
Stirling Products clinical trial listed on US websites -
29/04/10
Stirling Products' Inhalation Drug Delivery Device in design stage -
31/03/10
Stirling Products to commence HIV and Flu trials -
15/03/10
Stirling Products launches health products on Gold Coast -
04/03/10
Stirling Products appoints UK director -
03/03/10
Stirling Products in major pharmaceutical manufacturing facility deal in Canada -
01/03/10
Stirling Products requests trading halt pending update on pharmaceutical manufacturing facility -
12/02/10
Stirling Products evolves healthcare and pharmaceutical businesses -
28/01/10
Stirling Products has high hopes for ImmunoXel clinical trial to treat flu -
14/01/10
Stirling Products receives key US grant for ImmunoXel product, for treatment of TB and AIDS -
11/01/10
Stirling Products reports results of small trial in terminal TB/HIV patients -
30/12/09
Stirling Products appoints brand and marketing specialist to promote new business -
23/12/09
Stirling Products to launch generic pharmacy range in March -
02/12/09
Stirling Products inks conditional agreement to acquire Canadian pharmaceutical manufacturing facili -
26/11/09
Stirling Products raises $1.5 million through placement -
26/11/09
Stirling Products Peter Boonen points to a year of growth at today's AGM -
18/11/09
Stirling Products inks deal with Innovative Biotech to trial Immunoxel in Nigeria -
16/11/09
Stirling Products increases sales in Mongolia, readies for US-market launch
Sorry, no media files found.
